TY - GEN
T1 - Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
AU - Rodríguez, Yhojan
AU - Anaya, Juan Manuel
PY - 2018/9
Y1 - 2018/9
N2 - We read with great interest the recent publication by Geurtsvan Kessel et al.1 who, in a prospective study done between 2011 and 2015 in Bangladesh, sought to determine if the presence of ZIKV could be associated with GBS. After analyzing the presence of neutralizing antibodies in patients with GBS and healthy patients, it was concluded that there was no significant difference between cases and controls. Additionally, a subanalysis of two groups, patients with GBS and co‐infection with ZIKV and C. jejuni and GBS associated with ZIKV alone was done. This analysis made it possible to observe that there are clinical outcomes and electromyographical differences between these two groups
AB - We read with great interest the recent publication by Geurtsvan Kessel et al.1 who, in a prospective study done between 2011 and 2015 in Bangladesh, sought to determine if the presence of ZIKV could be associated with GBS. After analyzing the presence of neutralizing antibodies in patients with GBS and healthy patients, it was concluded that there was no significant difference between cases and controls. Additionally, a subanalysis of two groups, patients with GBS and co‐infection with ZIKV and C. jejuni and GBS associated with ZIKV alone was done. This analysis made it possible to observe that there are clinical outcomes and electromyographical differences between these two groups
UR - http://www.scopus.com/inward/record.url?scp=85051361262&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051361262&partnerID=8YFLogxK
U2 - 10.1002/acn3.602
DO - 10.1002/acn3.602
M3 - Carta
AN - SCOPUS:85051361262
SN - 2328-9503
VL - 5
SP - 1139
JO - Annals of Clinical and Translational Neurology
JF - Annals of Clinical and Translational Neurology
ER -